Fortrea Holdings (FTRE) Cash & Current Investments (2022 - 2026)

Fortrea Holdings (FTRE) reported Cash & Current Investments of $147.5 million for Q1 2026, up 45.18% on a YoY basis from $101.6 million in Q1 2025, and down 15.52% quarter-over-quarter from $174.6 million in Q4 2025.

Fortrea Holdings (FTRE) Cash & Current Investments (2022 - 2026) Analysis & Trends

Fortrea Holdings has reported Cash & Current Investments for 5 years, with the latest figure at $147.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash & Current Investments rose 45.18% year-over-year to $147.5 million; the trailing twelve-month figure through Mar 2026 stood at $147.5 million (up 45.18% YoY), and the FY2025 full-year result was $174.6 million, up 47.34% from the prior year.
  • Cash & Current Investments for Q1 2026 stood at $147.5 million, down from $174.6 million in the prior quarter.
  • The five-year high for Cash & Current Investments was $174.6 million in Q4 2025, with the low at $81.2 million in Q2 2025.
  • Historically, Cash & Current Investments has averaged $117.0 million across 5 years, with a median of $112.0 million in 2022.
  • The largest YoY upside for Cash & Current Investments was 47.34% in 2025 against a maximum downside of 35.66% in 2025.
  • Fortrea Holdings' Cash & Current Investments stood at $112.0 million in 2022, then slipped by 3.04% to $108.6 million in 2023, then advanced by 9.12% to $118.5 million in 2024, then jumped by 47.34% to $174.6 million in 2025, then decreased by 15.52% to $147.5 million in 2026.
  • The last three Cash & Current Investments figures came in at $147.5 million (Q1 2026), $174.6 million (Q4 2025), and $131.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 32.30 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 2.13 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 286.70 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 18.44 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 2.77 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 7.20 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 7.25 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Fortrea Holdings 1.43 Bn 1.28 Bn 123.60 Mn 147.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 147.50 Mn
Dec 31, 2025 174.60 Mn
Sep 30, 2025 131.30 Mn
Jun 30, 2025 81.20 Mn
Mar 31, 2025 101.60 Mn
Dec 31, 2024 118.50 Mn
Sep 30, 2024 105.30 Mn
Jun 30, 2024 126.20 Mn
Mar 31, 2024 92.80 Mn
Dec 31, 2023 108.60 Mn
Sep 30, 2023 107.50 Mn
Jun 30, 2023 114.30 Mn
Dec 31, 2022 112.00 Mn